越秀交通基建(01052.HK)附屬擬發行不超5億元公司債
格隆匯6月5日丨越秀交通基建(01052.HK)公告,內容關於公司全資附屬公司越秀(中國)交通基建投資有限公司("發行人")已取得上海證券交易所就註冊在中國面向專業投資者公開發行本金總額不超過人民幣30億元的公司債券("該公司債")額度並在上交所上市批準,並已完成向中國證券監督管理委員會註冊該公司債。
第一期該公司債最初本金總額爲不超過人民幣5億元,屬票面利率爲1.80%三年期債券。本次發行2025年第一期公司債券的募集資金不超過人民幣5億元,將用於償還發行人及其附屬公司的存量債務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.